Skip to main content
Livermore
Livermore
ZHEN

Walleye Trading LLC

SEC CIK
0001388391
Latest filing
Aug 3, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Walleye Trading LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
6,037
Value
$1.82M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of ALNY by Walleye Trading LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,037$1.82M<0.1%+281+4.9%AddedHolders
Q1 20265,756$1.90M<0.1%−2,901−33.5%ReducedHolders
Q4 20258,657$3.44M0.1%+7,062+442.8%AddedHolders
Q3 20251,595$727.3K<0.1%+1,252+365.0%AddedHolders
Q2 2025343$111.8K<0.1%−3,017−89.8%ReducedHolders
Q1 20253,360$907.3K<0.1%+3,360NewHolders
Q3 20240$00.0%−1,318−100.0%Sold outHolders
Q2 20241,318$320.3K<0.1%−23,854−94.8%ReducedHolders
Q1 202425,172$3.76M0.1%+2,661+11.8%AddedHolders
Q4 202322,511$4.31M0.1%+22,511NewHolders
Q3 20230$00.0%−4,489−100.0%Sold outHolders
Q2 20234,489$852.6K<0.1%−1,548−25.6%ReducedHolders
Q1 20236,037$1.21M<0.1%+6,037NewHolders
Q4 20220$00.0%−28,223−100.0%Sold outHolders
Q3 202228,223$5.65M0.2%+16,154+133.8%AddedHolders
Q2 202212,069$1.76M<0.1%+12,069NewHolders
Q1 20220$00.0%−3,305−100.0%Sold outHolders
Q4 20213,305$560.0K<0.1%+1,705+106.6%AddedHolders
Q3 20211,600$302.0K<0.1%−651−28.9%ReducedHolders
Q2 20212,251$382.0K<0.1%+1,597+244.2%AddedHolders
Q1 2021654$92.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.